TAAR1 levels and sub-cellular distribution are cell line but not breast cancer subtype specific

Trace Amines and Their Receptors

(2018) Raul R. Gainetdinov et al.   PHARMACOLOGICAL REVIEWS

Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers

(2018) Lisa M. Fleischer et al.   Frontiers in Pharmacology

Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer

(2017) Aurelia Vattai et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Breast cancer

(2017) Nadia Harbeck et al.   LANCET

Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

(2017) Mark D. Berry et al.   PHARMACOLOGY & THERAPEUTICS

Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study

(2016) Mette Søgaard et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Incretin-like effects of small molecule trace amine-associated receptor 1 agonists

(2016) Susanne Raab et al.   Molecular Metabolism

Clinical significance of tumor-infiltrating lymphocytes in breast cancer

(2016) Sasha E. Stanton et al.   Journal for ImmunoTherapy of Cancer

A Transcriptome-Led Exploration of Molecular Mechanisms Regulating Somatostatin-Producing D-Cells in the Gastric Epithelium

(2015) Alice Adriaenssens et al.   ENDOCRINOLOGY

Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers

(2015) Anja Harmeier et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Orchestrating high-throughput genomic analysis with Bioconductor

(2015) Wolfgang Huber et al.   NATURE METHODS

Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1

(2015) Stefano Espinoza et al.   NEUROPHARMACOLOGY

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line

(2015) Majid Pornour et al.   Recent Patents on Anti-Cancer Drug Discovery

HER2-directed therapy: current treatment options for HER2-positive breast cancer

(2015) Shahid Ahmed et al.   Breast Cancer

Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes

(2014) Irma E. Cisneros et al.   NEUROPHARMACOLOGY

Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2

(2013) A. Babusyte et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors

(2012) Grazia Chiellini et al.   JOURNAL OF ENDOCRINOLOGY

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

(2012) F G Revel et al.   MOLECULAR PSYCHIATRY

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

Trace Amine Associated Receptor 1 Signaling in Activated Lymphocytes

(2011) Michael W. Panas et al.   Journal of Neuroimmune Pharmacology

Evidence for functional trace amine associated receptor-1 in normal and malignant B cells

(2011) Agata M. Wasik et al.   LEUKEMIA RESEARCH

Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor

(2011) S. Espinoza et al.   MOLECULAR PHARMACOLOGY

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

(2011) F. G. Revel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A framework for oligonucleotide microarray preprocessing

(2010) Benilton S. Carvalho et al.   BIOINFORMATICS

Anatomical and histological profiling of orphan G-protein-coupled receptor expression in gastrointestinal tract of C57BL/6J mice

(2009) Junko Ito et al.   CELL AND TISSUE RESEARCH

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

(2009) Ana M. Gonzalez-Angulo et al.   JOURNAL OF CLINICAL ONCOLOGY

The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

(2009) A. Bradaia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants

(2008) Mark Kidd et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Anatomical Profiling of G Protein-Coupled Receptor Expression

(2008) Jean B. Regard et al.   CELL

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

(2008) C. Desmedt et al.   CLINICAL CANCER RESEARCH

G Protein-Coupled Receptors in and on the Cell Nucleus: A New Signaling Paradigm?

(2008) BENOIT BOIVIN et al.   JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor

(2008) L. S. Barak et al.   MOLECULAR PHARMACOLOGY